Evidence map›Paper›PMID 38968359›Full record

ReviewScience advances2024

Mitogen signaling strength and duration can control cell cycle decisions.

Ruth Nussinov, Wengang Zhang, Yonglan Liu, Hyunbum Jang

Abstract readReview
In one paragraph

Review in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Allostery in Biomolecular Condensates.Journal of molecular biology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Molecular principles underlying aggressive cancers.Signal transduction and targeted therapy · 2025
    Review
  11. Article
  12. Article
  13. Special Issue: MAPK Signaling Cascades in Human Health and Diseases.International journal of molecular sciences · 2024
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruth NussinovComputational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0002-8115-6415
Wengang ZhangCancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA.ORCID 0000-0001-9653-6966
Yonglan LiuCancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA.ORCID 0000-0001-5280-5992
Hyunbum JangComputational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0001-9402-4051

Funding

NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003I
6 · The paper itself

Abstract

Decades ago, mitogen-promoted signaling duration and strength were observed to be sensed by the cell and to be critical for its decisions: to proliferate or differentiate. Landmark publications established the importance of mitogen signaling not only in the G

Indexed as

Cell CycleCell DifferentiationSignal TransductionAnimalsCell ProliferationHumansMitogensMitogens

Identifiers

PMID38968359
PMCPMC11809619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.